1Department of Pharmacology, Government Medical College, Bhavnagar-364001, Gujarat, India
2Department of Pathology, Government Medical College, Bhavnagar-364001, Gujarat, India
Objectives: Cow urine ark (CUA), known as “Amrita” as mentioned in Ayurveda, contains anti-hyperglycemic and antioxidant effects. Therefore, we designed the present study to evaluate the lipid lowering activity of CUA and its possible implication in metabolic syndrome. Materials and Methods: Thirty guinea pigs of either sex were divided into five groups: Group 1 and 2 serving as a vehicle and sham control, received normal and high fat diet for 60 days respectively; Group 3, 4 and 5 received high fat diet for 60 days with CUA 0.8 ml/kg, 1.6 ml/kg and rosuvastatin (1.5 mg/kg) on thelast 30 days of study period, respectively. Serum lipid profile (total cholesterol, triglycerides, LDL-C, VLDL-C, HDL-C, total Cholesterol/HDL-C) and serum enzymes (ALT, AST, ALP, LDH and CK-MB) were performed in each group at the beginning and end of the study. Histological study of liver and kidney was done in each group. Results: CUA (0.8 ml/kg) significantly decreased the serum triglycerides and VLDL-C, but CUA (1.6 ml/kg) decreased the total serum Cholesterol, triglycerides and VLDL-C (p < 0.05). Higher dose (1.6 ml/kg) of CUA also increased HDL-C level, significantly (p < 0.05). CUA reduced serum AST, ALP and LDH level, which was statistically significant as well, while it also decreased the accumulation of lipid in hepatocytes as compared to sham control. Conclusions: CUA reduced triglycerides, increased HDL-C and found to be hepatoprotective in animals that are on a high fat diet.
Achliya GS, Kotagale NR, Wadodkar SG, Dorle AK. 2003. Hepatoprotective activity of panchagavyaghrita against carbon tetrachloride induced hepatotoxicity in rats. Indian J Pharmacol, 35: 308-311.
Ahmad-Raus RR, Abdul-Latif ES, Mohammad JJ. 2001. Lowering of lipid composition in aorta of guinea pigs by Curcuma domestica. BMC Complement Altern Med, 1: 6-11.
Anchala R, Pant H, Prabhakaran D, Franco OH.2012. ‘Decision support system (DSS) for prevention of cardiovascular disease (CVD) among hypertensive (HTN) patients in Andhra Pradesh, India’--a cluster randomised community intervention trial. BMC Public Health, 12: 393-399.
Badimon L, Vilahur G, Padro T.2010. “Nutraceuticals and atherosclerosis: human trials.” CardiovasTher, 28: 202-215.
Bo S, Durazzo M, Gambino R, Berutti C, Milanesio N, Caropreso A, Gentile L, CassaderM, Cavallo-Perin P, Pagano G.2008. Associations of dietaryand serum copper with inflammation, oxidativestress, and metabolic variables in adults. J Nutr, 138: 305-310.
Botham KM, Moore EH, De Pascale C, Bejta F. 2007.The induction of macrophage foam cell formation by chylomicron remnants.BiochemSoc Trans, 35: 454-458.
Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004; 350: 1495-1504.
Demacker PN, Reijnen IG, Katan MB, Stuyt PM, Stalenhoef AF.1991. Increased removal of remnants of triglyceride-rich lipoproteins on a diet rich in polyunsaturated fatty acids. EurJ Clin Invest, 21: 197-203.
Dhama K, Chauhan RS, Singhal L.2005. Anti-Cancer activity of cow urine: Current status and future directions. Int J Cow Sci, 1: 1-25.
Fernandez ML, Volek JS.2006. Guinea pigs: a suitable animal model to study lipoprotein metabolism, atherosclerosis and inflammation. NutrMetab (Lond), 3: 17-23.
Freedman JE.2003.“High-fat diets and cardiovascular disease.”Jacc, 41: 1750-1752.
Friedewald WT, Levy RI, Fredrickson DS.1972.Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.ClinChem, 18: 499-502.
Fruchart JC.2013. Selective peroxisome proliferator-activated receptor α modulators (SPPARMα): the next generation of peroxisome proliferator-activated receptor α-agonists. CardiovascDiabetol, 12: 1-8.
Gianturco SH, Ramprasad MP, Song R, Li R, Brown ML, Bradley WA.1998. Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride rich lipoproteins to their unique human monocytemacrophage receptor. ArteriosclerThrombVascBiol, 18: 968-976.
Goldstein JL, Kita T, Brown MS.1983. Defective lipoprotein receptors and atherosclerosis.Lessons from an animal counterpart of familial hypercholesterolemia. N Engl J Med, 309: 288-296.
Gururaja M P, Joshi A B, Joshi H, Sathyanarayana D, Subrahmanyam EVS, ChandrashekharKS.2011. Antidiabetic potential of cow urine in streptozotocin induced diabetic rats. Asian J Tradit Med, 6: 8-13.
Jain NK, Gupta VB, Garg R, Silawat N.2010. Efficacy of cow urine therapy on various cancer patients in Mandsaur district, India: A survey. Int J Green Pharm, 4: 29-35.
Jarald EE, Edwin S, Tiwari V, Garg R,
Toppo E.2008. Antidiabetic activity of cow urine and a herbal preparation prepared using cow urine. Pharm Biol, 46: 789-792.
Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM.2006. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation, 114: 681-687.
Krishnamurthi K, Dutta D, Sivanesan SD, Chakrabarti T.2004. Protective effect of distillate and redistillate of Cow's urine in human polymorphonuclear leukocytes challenged with established genotoxic Chemicals. Biomed Environ Sci, 17: 247-256.
Kwiterovich Jr. PO.1997. “The effect of dietary fat, antioxidants, and pro-oxidants on blood lipids, lipoproteins, and atherosclerosis.” Journal Am Diabet Association, 97: 31-41.
Lamb DJ, Avades TY, Ferns GA.2001. Biphasic modulation of atherosclerosis induced by graded dietary copper supplementation in the cholesterol-fedrabbit. Int J ExpPathol, 82: 287-294.
LaRosa JC, Grundy SM, Waters DD, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM.2005. Intensive lipid lowering with atorvastatin in patientswith stable coronary disease. N Engl J Med, 352: 1425-1435.
Li M, Li Y, Liu J.2013. Metabolic syndrome with hyperglycemia and the risk of ischemic stroke.Yonsei Med J, 54: 283-287.
Palmer AM, Murphy N, Graham A.2004. Triglyceride-rich lipoproteins inhibit cholesterol efflux to apolipoprotein (apo) A1 from human macrophage foam cells. Atherosclerosis, 173: 27-38.
Patel S, Puranik R, Nakhla S, Lundman P, Stocker R, Wang XS, Lambert G, Rye KA, Barter PJ, Nicholls SJ, CelermajerDS.2009. Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis, 204: 424-428.
Patel Y, Vadgama V, Baxi S, Chandrabhanu, Tripathi B. 2011. Evaluation of hypolipidemicactivity of leaf juice of Catharanthusroseus (Linn.) G. Donn. in guinea pigs. Acta Pol Pharm, 68: 927-935.
Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J.2005. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA, 294: 2437-2445.